JP2003524573A5 - - Google Patents

Download PDF

Info

Publication number
JP2003524573A5
JP2003524573A5 JP2000506968A JP2000506968A JP2003524573A5 JP 2003524573 A5 JP2003524573 A5 JP 2003524573A5 JP 2000506968 A JP2000506968 A JP 2000506968A JP 2000506968 A JP2000506968 A JP 2000506968A JP 2003524573 A5 JP2003524573 A5 JP 2003524573A5
Authority
JP
Japan
Prior art keywords
mecamylamine
composition
group
dimethylaminomecamylamine
stereoisomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000506968A
Other languages
English (en)
Japanese (ja)
Other versions
JP4640888B2 (ja
JP2003524573A (ja
Filing date
Publication date
Priority claimed from PCT/US1997/020689 external-priority patent/WO1999007356A1/en
Application filed filed Critical
Priority claimed from PCT/US1998/016634 external-priority patent/WO1999007378A1/en
Publication of JP2003524573A publication Critical patent/JP2003524573A/ja
Publication of JP2003524573A5 publication Critical patent/JP2003524573A5/ja
Application granted granted Critical
Publication of JP4640888B2 publication Critical patent/JP4640888B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000506968A 1997-08-11 1998-08-11 神経精神性疾患用ニコチンアンタゴニスト Expired - Fee Related JP4640888B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US5523497P 1997-08-11 1997-08-11
US60/055,234 1997-08-11
US93536497A 1997-09-22 1997-09-22
US08/935,364 1997-09-22
US9720689 1997-11-07
PCT/US1997/020689 WO1999007356A1 (en) 1997-08-11 1997-11-07 Nicotine antagonists for neuropsychiatric disorders
PCT/US1998/016634 WO1999007378A1 (en) 1997-08-11 1998-08-11 Nicotine antagonists for nicotine-responsive neuropsychiatric disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010068970A Division JP2010159285A (ja) 1997-08-11 2010-03-24 神経精神性疾患用ニコチンアンタゴニスト

Publications (3)

Publication Number Publication Date
JP2003524573A JP2003524573A (ja) 2003-08-19
JP2003524573A5 true JP2003524573A5 (https=) 2009-05-28
JP4640888B2 JP4640888B2 (ja) 2011-03-02

Family

ID=27368798

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000506968A Expired - Fee Related JP4640888B2 (ja) 1997-08-11 1998-08-11 神経精神性疾患用ニコチンアンタゴニスト

Country Status (6)

Country Link
JP (1) JP4640888B2 (https=)
AU (1) AU8778498A (https=)
CA (1) CA2300148C (https=)
DK (1) DK1011678T3 (https=)
ES (1) ES2299214T3 (https=)
WO (1) WO1999007378A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL348107A1 (en) * 1998-10-16 2002-05-06 Janssen Pharmaceutica Nv Therapy for improving cognition
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
WO2005063296A2 (en) * 2003-12-23 2005-07-14 Pfizer Products Inc. Therapeutic combination for cognition enhancement and psychotic disorders
EP1863485A2 (en) * 2005-03-18 2007-12-12 Abbott Laboratories Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions
US11766429B1 (en) 2020-08-26 2023-09-26 University Of South Florida Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-19

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691365A (en) * 1995-07-18 1997-11-25 University Of Kentucky Research Foundation Nicotinic receptor antagonists in the treatment of neuropharmacological disorders

Similar Documents

Publication Publication Date Title
AU2021382158B2 (en) Mdma prodrugs to assist psychotherapy
CN101772346B (zh) 用于降低治疗副作用的方法和组合物
JP2002532392A (ja) エキソ−ｓ−メカミラミン製剤および治療におけるその使用
CA2375908A1 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
JPH09503778A (ja) 鎮痛剤およびその使用
CN110996947A (zh) N-甲基-d-天冬氨酸型谷氨酸受体拮抗剂反应性神经精神性疾病的联合治疗
JP2003176240A (ja) ニコチン性アセチルコリン受容体作用薬により関節の潤滑を高める方法
JP2009517393A (ja) 不安症の治療方法
US20180110768A1 (en) Methods and compositions for reduction of side effects of therapeutic treatments
WO2024206000A2 (en) Mdma prodrugs to assist psychotherapy
JP2003524573A5 (https=)
ES2210025T3 (es) Agente farmaceutico para el tratamiento de estados convulsivos.
JP4640888B2 (ja) 神経精神性疾患用ニコチンアンタゴニスト
Ulm Effect of budipine on parkinsonian tremor resistant to other antiparkinsonian medication
Schneider et al. Long-term effects of high-dose ISDN therapy in patients with coronary heart disease
WO1999007356A1 (en) Nicotine antagonists for neuropsychiatric disorders
DE69910242D1 (de) Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen
Feighner Clinical overview of serotonin re-uptake inhibitors
AU2011203482B2 (en) Methods and compositions for reduction of side effects of therapeutic treatments
HK1076736A (en) Method of promoting smoking cessation